CinDome Pharma announces successful completion of thorough QT study of CIN- 102

CinDome Pharma announced the negative results of a clinical thorough QT/QTc study of CIN-102.

CinFina Pharma In-Licenses Obesity Portfolio

CinFina Pharma announced that it has signed an agreement with Janssen Sciences.

INVESTOR INQUIRIES

CAREER INQUIRIES

GENERAL INQUIRIES